Marksans Pharma Limited has informed the Exchange about press release dated 21-Jul-2022 titled US FDA approval for Pregabalin Capsules, 25 mg, 50 mg,75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg ANDA.
Marksans Pharma Limited has informed the Exchange about press release dated 21-Jul-2022 titled US FDA approval for Pregabalin Capsules, 25 mg, 50 mg,75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg ANDA.